Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer

NCT00961077 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Elderly
S-1
Oxaliplatin
First-Line
Gastric Cancer

Interventions

DRUG: S-1 (TS-1) and Oxaliplatin (Oxalitin)

Sponsor

Soonchunhyang University Hospital